Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
about
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgeryPrognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 casesOverexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaDescriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United StatesEpigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical MeningiomaThe Rare Cancer Network: achievements from 1993 to 2012Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survivalExpression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.Radiation Treatment for WHO Grade II and III MeningiomasAnatomic location is a risk factor for atypical and malignant meningiomas.Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas.Advances in meningioma therapy.A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.A review of malignant meningiomas: diagnosis, characteristics, and treatment.Tumors of the anterior skull base.Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway.Gamma Knife Stereotactic Radiosurgery for Grade 2 Meningiomas.Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.Papillary meningioma: an aggressive variant meningioma with clinical features and treatment: a retrospective study of 10 cases.Atypical and anaplastic meningiomas in a public hospital in São Paulo State, Brazil.Review of Current Evidence Regarding Surgery in Elderly Patients with Meningioma.Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.The role of adjuvant radiotherapy in atypical meningioma.Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.Stereotactic radiosurgery for WHO II and III meningiomas: analysis of long-term clinical and radiographic outcomes.Amide proton transfer imaging for differentiation of benign and atypical meningiomas.Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment.Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma.Radiosurgery for atypical and anaplastic meningiomas: histopathological predictors of local tumor control.Role of stereotactic radiosurgery in meningiomas and vestibular schwannomas.WHO grade II and III meningiomas: a study of prognostic factors.Proton therapy for atypical meningiomas.A study of prognostic factors in 45 cases of atypical meningioma.
P2860
Q30448386-0FE8A89A-DC3A-4EB9-8A14-8563A4F59D17Q33599285-FDE0FBA9-7EF8-4ABA-9C97-7B5F4FB610B7Q33742685-B1F2B3A8-DFC3-4B9D-BFDB-E7948FB7368DQ35017362-AE49E4DB-6AA2-4CBC-9C6A-C41B5A381A7AQ35628908-923C9900-36F5-42D9-8ECD-0AB88A6CA036Q35741539-C341307D-0A68-46C5-AFD4-4D55669E4C5DQ35815316-59822B4F-F33F-4B1A-8F48-4CE45A341751Q35905146-08C77875-EC6C-471A-AE72-374B47A303B0Q36331769-F68DC838-17C0-4843-8A7E-87A5DE909E9FQ36584592-90FE0857-9135-49B0-8C3F-096A33B0B6C1Q36943867-E192C7EA-66FB-4225-A62C-318112B0439BQ37137653-CD5075E4-CAF8-48AC-8820-5BE0E647E3EEQ37226853-73DC8779-7500-41D8-B708-A4C5FAB7F475Q37352522-1A31BA16-1855-4760-B333-458285E3706CQ37434663-1F8626F8-D04A-4498-958F-D7AD62D22E87Q37581072-548E6CED-DFCA-472A-9368-37B1ED84460BQ37781728-37C4C35C-4D7C-4129-84AC-13D4CB4DF690Q38190591-0D35BA9A-CC4C-49D4-BA7E-EBE966FFC5F6Q38201701-36E11D9D-AE7A-477B-9FE5-8BAE273E0C53Q38711744-0141CEDB-03FB-436B-9D8E-59F5D349AFDFQ38888517-547E84BB-77DE-42DB-8F8C-17548D03B863Q39446290-C239194E-6B9C-4039-B521-9A9C33817B03Q39944235-95AA8A05-BDDE-4DBD-882C-69288B7229F1Q40615167-60690DBD-681F-490F-A7AF-B2DD02E18206Q41384859-9929C8F3-D6C8-4F2B-A6BB-E681B2DD868BQ42257960-91EEEF23-7A86-4799-B884-09183DA52D35Q44596691-2F3DB672-1F38-4E92-8DF8-A14AAB680F4DQ45859959-9B82FF63-A61C-444F-884E-467AE4CD1EEEQ46614069-DF9B631F-2302-4CCC-AA43-E3EE63C66185Q46649981-AAD9959C-EC7C-4C4D-8FFA-811767F87AAEQ47105670-A49BA6AB-BCF5-4678-AF8B-F6D8C5BFC3CEQ48036634-D841773D-8222-47A1-8B00-10AB9AE34F5BQ48176888-D3F2C922-2496-400C-9914-8B48429DFCD0Q48184630-630F755B-6C6D-40C9-95FC-1074C0CEFDDCQ48249218-E0457C5B-7495-42AD-B80A-FE0BB097B468Q48439566-CC6BF231-AFDD-47E4-AA2D-0100AAD30DDFQ50354820-1ED44329-F0B5-4A34-BD1B-B956FACC1769Q51822733-CC9FF0AF-88B4-4A54-A4A3-BF0611405C61Q53548356-5889B242-AD86-45AA-A3E4-D86EC1ECC621Q53755702-0BB98378-0BA9-4062-A39A-48293A66FD26
P2860
Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@en
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@nl
type
label
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@en
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@nl
prefLabel
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@en
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@nl
P2093
P1476
Atypical and malignant meningi ...... dy of the Rare Cancer Network.
@en
P2093
Brigitta G Baumert
Damien C Weber
Deniz Yalman
Emine Canyilmaz
Ewa Szutowicz
Marco Krengli
Nicolas Rezvoy
Rare Cancer Network
René O Mirimanoff
Salvador Villa
P304
P356
10.1016/J.IJROBP.2007.12.020
P407
P577
2008-03-04T00:00:00Z